REMS
Contraindicated in:
Use Cautiously in:
CV: hypertension(IV), hypotension(IV)
Derm: ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS, rash, STEVENS-JOHNSON SYNDROME (SJS), TOXIC EPIDERMAL NECROLYSIS, urticaria
F and E: hypokalemia(IV)
GI: ↑liver enzymes, constipation(↑ in children) (IV), HEPATOTOXICITY (WITH HIGHER DOSES), nausea(IV), vomiting(IV)
GU: renal failure(high doses/chronic use)
Hemat: neutropenia, pancytopenia
MS: muscle spasms (IV)
Neuro: agitation (↑ in children) (IV), anxiety(IV), fatigue(IV), headache(IV), insomnia(IV)
Resp: atelectasis(↑ in children) (IV), dyspnea(IV)
Drug-drug:

Absorption: Well absorbed following oral administration. Rectal absorption is variable. Intravenous administration results in complete bioavailability.
Distribution: Widely distributed.
Half-Life: Neonates: 7 hr; Infants and Children: 34 hr; Adults: 13 hr.
( analgesia and antipyresis)
| ROUTE | ONSET | PEAK | DURATION |
|---|---|---|---|
| PO | 0.51 hr | 13 hr | 38 hr‡ |
| Rect | 0.51 hr | 13 hr | 34 hr |
| IV‡ | within 30 min | 30 min | 46 hr |
‡Depends on dose.
‡Antipyretic effects.
NDC Code